MEHMET OKCU to Survivors
This is a "connection" page, showing publications MEHMET OKCU has written about Survivors.
Connection Strength
0.987
-
Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020 02; 67(2):e28064.
Score: 0.139
-
Prevalence and Predictors of Overweight and Obesity Among a Multiethnic Population of Pediatric Acute Lymphoblastic Leukemia Survivors: A Cross-Sectional Assessment. J Pediatr Hematol Oncol. 2016 08; 38(6):429-36.
Score: 0.111
-
Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy. Pediatr Blood Cancer. 2011 Sep; 57(3):454-60.
Score: 0.077
-
Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia. Cancer. 2009 Sep 15; 115(18):4238-45.
Score: 0.069
-
Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr. 2008 Jan; 152(1):101-5.
Score: 0.060
-
Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group. Arch Pediatr Adolesc Med. 2007 Aug; 161(8):798-806.
Score: 0.059
-
Barriers to long-term follow-up in pediatric Hodgkin lymphoma survivors. Pediatr Blood Cancer. 2024 Apr; 71(4):e30855.
Score: 0.046
-
Neurologic morbidity and functional independence in adult survivors of childhood cancer. Ann Clin Transl Neurol. 2024 02; 11(2):291-301.
Score: 0.046
-
Leuprolide Protects Ovarian Reserve in Adolescents Undergoing Gonadotoxic Therapy. J Adolesc Young Adult Oncol. 2023 12; 12(6):828-834.
Score: 0.044
-
Superior verbal learning and memory in pediatric brain tumor survivors treated with proton versus photon radiotherapy. Neuropsychology. 2023 Feb; 37(2):204-217.
Score: 0.043
-
Predicting neurocognitive function in pediatric brain tumor early survivorship: The neurological predictor scale and the incremental validity of tumor size. Pediatr Blood Cancer. 2022 09; 69(9):e29803.
Score: 0.042
-
Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy. Pediatr Blood Cancer. 2022 06; 69(6):e29645.
Score: 0.041
-
Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcoma. J Cancer Surviv. 2023 08; 17(4):1238-1250.
Score: 0.041
-
Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. Genet Med. 2020 11; 22(11):1794-1802.
Score: 0.036
-
Predictors of Suboptimal Follow-up in Pediatric Cancer Survivors. J Pediatr Hematol Oncol. 2017 04; 39(3):e143-e149.
Score: 0.029
-
Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Clin Cancer Res. 2014 Feb 15; 20(4):904-11.
Score: 0.023
-
Long-term outcome of centrally located low-grade glioma in children. Cancer. 2013 Jul 15; 119(14):2630-8.
Score: 0.022
-
Human papillomavirus vaccination in female pediatric cancer survivors. J Pediatr Adolesc Gynecol. 2012 Oct; 25(5):305-7.
Score: 0.021
-
Antioxidant enzyme polymorphisms and neuropsychological outcomes in medulloblastoma survivors: a report from the Childhood Cancer Survivor Study. Neuro Oncol. 2012 Aug; 14(8):1018-25.
Score: 0.021
-
Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol. 2008 Sep 01; 26(25):4138-43.
Score: 0.016